Tag: gastroparesis market scope

  • Gastroparesis Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities

    Gastroparesis Market Insights 2025-2034: Growth Dynamics, Trends, and Strategic Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the gastroparesis market grown in recent years?

    The market for gastroparesis has seen a gradual increase in its size in the last few years. The market is set to expand from its 2024 size of $6.84 billion to $7.17 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 4.9%. The previous period of growth can be ascribed to factors such as the ageing population, a rise in diabetes cases, better comprehension of gastro-related conditions, development in treatment methodology, and heightened awareness of gastroparesis.

    How is the gastroparesis market size expected to evolve during the forecast period?

    The market for gastroparesis is projected to witness significant expansion in the forthcoming years. The anticipated market value is $8.82 billion by 2029, progressing at a compound annual growth rate (CAGR) of 5.3%. The expected growth during the forecast period can be accredited to the innovations in therapeutic treatments, the proliferation of individualized medicine tactics, the incorporation of digital health solutions, the escalation in health care facilities, and a rising emphasis on early diagnosis. Key trends for the predicted period include progression in gastric electrical stimulation therapy, burgeoning research in stem cell treatment, the shift towards minimally invasive surgical procedures, growing dependency on wearable health monitoring gadgets, and emphasis on patient-centered care paradigms.

    Get your gastroparesis market report here!

    https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

    Which key drivers are propelling the gastroparesis market’s growth?

    The rise in funds dedicated to health services is expected to enhance the expansion of the gastroparesis market. These health care expenditures cover costs attributed to hospitals, health professionals, nursing, dental care, medications, and public health measures, among other things. The amplified expenditure in healthcare can be linked to aspects such as an increasing elderly population, medical technology advancements, higher rates of chronic diseases, and escalating consumer demands for better healthcare provisions. This upsurge in health care spending positively influences the gastroparesis market by providing increased monetary support for exploration and progression, widening the range of treatment options, and granting patients enhanced access to specialized medical services. For example, a study by the Office for National Statistics, a UK government department, stated that, from 2022 to 2023, healthcare outlays in the UK rose by 5.6% as opposed to the 0.9% growth in 2022. It was documented that the UK expended approximately $317.63 billion (£292 billion) on healthcare in 2023. Consequently, the progression of healthcare spending is stimulating the growth of the gastroparesis market.

    What are the market segments in the gastroparesis industry?

    The gastroparesis market covered in this report is segmented –

    1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

    2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

    3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

    4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

    5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

    Subsegments:

    1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

    2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

    3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

    4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

    Which leading companies are shaping the growth of the gastroparesis market?

    Major companies operating in the gastroparesis market include Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Bausch Health Companies Inc., Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical co. ltd, ReGenXBio Inc., ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., Theravance Biopharma Inc., RedHill Biopharma Ltd., Valeant Pharmaceuticals International Inc., CinRx Pharma LLC., Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

    What key trends are currently impacting the gastroparesis market’s development?

    Leading firms in the gastroparesis market are introducing novel devices aimed at enhancing their market profitability. These therapy tools for gastroparesis, a disease marked by slow stomach emptying, are specially created to control or reduce related symptoms. For example, a US medical device firm, Enterra Medical Inc., unveiled a new therapy named Enterra for gastroparesis treatment in 2022. The Enterra Therapy system leverages an embedded neurostimulator to generate mild electrical pulses, promising potential relief for chronic nausea and vomiting symptoms associated with gastroparesis. This treatment is intended for individuals between the ages of 18 to 70 years who suffer from chronic, uncontrollable nausea and vomiting that is drug-resistant and is associated with gastroparesis of diabetic or idiopathic nature.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12189

    Which geographic areas are influencing the growth of the gastroparesis market?

    North America was the largest region in the gastroparesis market in 2024. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Specialty Trade Contractors Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/specialty-trade-contractors-global-market-report

    Repair and Maintenance Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

    Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/services-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Gastroparesis Market Report 2024: Size, Drivers, And Top Segments

    Global Gastroparesis Market Report 2024: Size, Drivers, And Top Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How is the Gastroparesis Market Expected to Expand from 2024 to 2033?

    In the past few years, the size of the gastroparesis market has significantly expanded. It is expected to increase from $6.44 billion in 2023 to $6.8 billion in 2024, with a compound annual growth rate (CAGR) of 5.6%. The past growth can be attributed to factors such as an aging population, a rising prevalence of diabetes, increased comprehension of gastrointestinal disorders, development in treatment protocols, and heightened awareness about gastroparesis.

    The market size of gastroparesis is projected to witness consistent growth in the coming years, potentially reaching $8.19 billion by 2028 with a compound annual growth rate (CAGR) of 4.8%. The expected growth during this period can be linked to the advent of advanced therapeutic alternatives, the proliferation of personalized treatment strategies, the implementation of digital health solutions, the escalation of healthcare facilities, and a heightened emphasis on early diagnosis. Future trends encompassing this period may involve breakthroughs in gastric electrical stimulation therapy, expanding stem cell research, the incorporation of less invasive surgical procedures, the rise of wearable health tracking equipment, and a spotlight on care models centered on the patient.

    Claim Your Free Sample of the Global Gastroparesis Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

    What Influences Are Propelling the gastroparesis Market Forward?

    The uptick in gastroparesis incidences is predicted to boost the development of the gastroparesis market. Gastroparesis, a health issue that halts or slows the transition of food from the stomach to the small intestinal tract, is usually caused by hypothyroidism, autoimmune disorders, vagus nerve damage, or viral stomach infections. Medication for gastroparesis works by tensing and contracting the stomach wall muscles, thereby enhancing gastric emptying. An online Netherlands-based research articles publisher, Practice Update, in a study published in 2021, stated that the total prevalence rate of gastroparesis in the US was 267.7 out of 100,000 people. The confirmed gastroparesis prevalence rate was 21.5 out of 100,000 people. Consequently, the rising prevalence of gastroparesis is fueling the expansion of the gastroparesis treatment market.

    What Key Segments Exist Within the Gastroparesis Market?

    1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

    2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

    3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

    4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

    5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

    What Trends Are Coming to the Forefront in the Gastroparesis Market?

    In the gastroparesis market, leading companies are focusing on the creation of cutting-edge devices to enhance their profitability. These devices for gastroparesis treatment are specially designed medical tools or equipment used to control or lessen the symptoms related to gastroparesis, a disorder marked by slow stomach emptying. For example, in 2022, Enterra Medical Inc., an American medical device firm, introduced an enterra therapy for managing gastroparesis. The Enterra Therapy system operates through an implanted neurostimulator that generates soft electrical pulses, providing potential relief for chronic nausea and vomiting symptoms associated with gastroparesis. This therapeutic approach is intended for individuals between the ages of 18 and 70 who suffer from chronic, unmanageable nausea and vomiting related to diabetic or idiopathic gastroparesis.

    Order Now for Fast Delivery of Your Gastroparesis Market Report!

    https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

    What Regions Are Leading the Charge in the Gastroparesis Market?

    North America was the largest region in the gastroparesis market in 2023. The regions covered in the gastroparesis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Gastroparesis Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the gastroparesis market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Gastroparesis Market Include

    1. Gastroparesis Market Executive Summary

    2. Gastroparesis Market Segments

    3. Gastroparesis Market Size And Template Market Growth Rate

    4. Key Gastroparesis Market Trends

    5. Major Gastroparesis Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Gastroparesis Market

    26. Top Gastroparesis Companies

    27. Gastroparesis Market Opportunities And Strategies

    28. Gastroparesis Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Global Gastroparesis Market Key Insights 2024-2033

    Global Gastroparesis Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Gastroparesis Global Market Report 2024, the gastroparesis market is expected to show promising growth in the forecast period.

    The gastroparesis market is witnessing robust growth, with a trajectory set to continue over the coming years. Factors contributing to this growth include:

    • Aging Population: As demographics shift, the incidence of gastroparesis increases, driving demand for treatment options.
    • Prevalence of Diabetes: With diabetes becoming more prevalent worldwide, the risk of developing gastroparesis rises, further fueling market expansion.
    • Improved Understanding of Gastrointestinal Disorders: Advances in medical research and diagnostics enhance the identification and management of gastroparesis cases.
    • Evolving Treatment Protocols: The development of new therapeutic approaches and protocols improves patient outcomes and drives market growth.
    • Growing Awareness: Increased awareness among both healthcare professionals and the general population leads to earlier diagnosis and intervention, boosting market demand.

    View More On The Gastroparesis Market Report 2024 – https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

    New Devices Transforming Gastroparesis Management

    Innovative devices play a crucial role in reshaping gastroparesis management, offering novel solutions to address patient needs. Key developments include:

    • Enterra Therapy: Introduced by Enterra Medical Inc. in 2022, this neurostimulation system provides targeted relief for chronic nausea and vomiting associated with gastroparesis.
    • Segment Analysis: The gastroparesis market is segmented based on various parameters, including treatment modality, gastroparesis type, patient demographics, distribution channels, and end-users.
    • Market Dynamics: North America emerges as a dominant region in the gastroparesis market, reflecting significant growth opportunities and market presence.

    Key Market Players and Competitive Landscape

    A multitude of companies are actively engaged in the gastroparesis market, driving innovation and competition. Major players include:

    • Pfizer Inc.
    • GlaxoSmithKline plc.
    • Abbott Laboratories Inc.
    • AstraZeneca Plc.
    • Medtronic Plc.
    • Takeda Pharmaceutical Company Limited
    • Novo Nordisk AS
    • Johnson And Johnson Services Inc.
    • Teva Pharmaceutical Industries Ltd.
    • AbbVie Inc.

    Future Trends and Forecast

    The gastroparesis market is poised for continued expansion, with a projected CAGR of 4.8% through 2028. Key trends shaping the market include:

    • Advancements in Gastric Electrical Stimulation Therapy: Ongoing research and development efforts aim to enhance the efficacy and accessibility of gastric electrical stimulation for gastroparesis management.
    • Stem Cell Therapy: Growing interest in regenerative medicine approaches, such as stem cell therapy, holds promise for addressing gastroparesis and its associated symptoms.
    • Minimally Invasive Surgical Interventions: The adoption of minimally invasive techniques minimizes patient discomfort and accelerates recovery, driving demand for surgical interventions.
    • Wearable Health Monitoring Devices: The integration of wearable technologies enables continuous monitoring of gastrointestinal function, facilitating personalized treatment approaches.
    • Patient-Centric Care Models: A shift towards patient-centric care emphasizes individualized treatment plans and holistic management strategies, improving patient outcomes and satisfaction.

    Conclusion

    As the prevalence of gastroparesis continues to rise, the market for its treatment and management is experiencing significant growth. With a diverse range of therapeutic options and innovative devices entering the market, patients have access to more effective and tailored interventions than ever before. Looking ahead, continued advancements in medical technology, coupled with a focus on personalized care and early intervention, are poised to drive further expansion and improvement in gastroparesis treatment outcomes.

    Request A Sample Of The Global Gastroparesis Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12189&type=smp